跳至主要内容
临床试验/NCT04325685
NCT04325685已完成不适用

The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia and Associated Microbiomes.

Northern State Medical University1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年1月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Incidence of ventilator-associated pneumonia (VAP)

研究概览

简要总结

Oropharynx is the main source of pathogen microorganisms for the ventilator - associated pneumoniae. As known bacteriophages can eliminate different pathogen microorganisms or reduce a degree of a pathogen's colonization. The research team is considering that oropharyngeal decontamination with bacteriophages can prevent the developing of the ventilator - associated pneumoniae. There will be three groups in this investigation: placebo, antiseptic drug (Octenisept) and bacteriophage (Sexthaphag).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • invasive mechanical ventilation beyond 48 hours

排除标准

  • hospital - acquired pneumonia
  • community - acquired pneumoniae
  • BMI > 35 kg/cm2
  • pregnancy
  • tracheostomy
  • reintubation

研究组 & 干预措施

Control group

Placebo Comparator

干预措施: Control (Drug)

Antiseptic (Octenisept) group

Active Comparator

干预措施: Antiseptic Solution (Drug)

Bacteriophage (Sextaphag) group

Experimental

干预措施: Bacteriophage (Drug)

结局指标

主要结局

Incidence of ventilator-associated pneumonia (VAP)

时间窗: Change from Baseline CPIS at 14 days

CPIS is using for diagnosis the VAP, if CPIS equal or more 6, the VAP will be confirmed

Changing of oral and lung microbiomes

时间窗: Change from Baseline Microbiology researching at 14 days

Microbiology researching samples from oral cavity and trachea. The Gram positive and Gram negative aerobes and anaerobes will be assessed with observing Colony Form Unit

次要结局

  • Concentration of C - reactive protein (CRP)(Change from Baseline CRP at 14 days)
  • Organ dysfunction(Change from Baseline Sequential Organ Function Assessment at 14 days)
  • Concentration of Procalcitonin (PCT)(Change from Baseline PCT at 14 days)
  • Rate of Mortality(Change from Baseline PCT at 28 days)

研究者

发起方
Northern State Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Vsevolod V. Kuzkov

Principal investigator

Northern State Medical University

研究点 (1)

Loading locations...

相似试验